Coloplast - Premium Valuation And Pedestrian Results Have Been A Bad Mix

2026-01-02 16:53:50 ET

If you’re going to be expensive, you had better be good, and Coloplast ( CLPBY ) ( CLPBF ) (COLO-B.CO) hasn’t been keeping up its end of the bargain. This leading player in ostomy and continence care has seen four straight quarterly misses at the top line and less margin leverage than expected, as well as a reset to lower growth expectations over the next three years. What’s more, a CEO search remains ongoing as of this writing....

Read the full article on Seeking Alpha

For further details see: